Join us for the second Digital Biomarker Summit USA, which will reconvene industry thought leaders on May 14, 2024, to share updates and new work within the digital health technology and digital biomarker space. 

This year's one-day event will discuss how the industry can work together on digital measurement and digital endpoints, share case studies on recent work on digital biomarkers in clinical trials, provide examples of how wearables play a role within AI, digital phenotyping and its impact on observational research, and spotlight updates on regulatory readiness to adopt these new ways of measuring endpoints.

Just a few decades ago, we relied on wristwatches to tell us the time. Today, a quick flick of the wrist can tell us so much more: our pulse, activity levels, sleep patterns; even our blood oxygen levels.

Digital Health Technologies (DHTs) such as smartwatches and other sensor technologies like fitness trackers, eyeglasses, shoe insoles, and other familiar objects we all carry or wear, are now more prevalent in society, transforming how people track and manage their own health data. And with the increase in the reliability and accessibility of DHTs, the healthcare industry is working to incorporate these technologies and revolutionize and resulting digital biomarkers into clinical studies.